Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 11-2012 | 09-2012 | 08-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,869 | -30,344 | -11 | -16,813 | -7 |
| Depreciation Amortization | 52 | 125 | N/A | 73 | N/A |
| Accounts payable and accrued liabilities | -2,751 | 2,979 | 2 | 675 | 1 |
| Other Working Capital | -2,864 | 3,114 | 2 | 636 | 1 |
| Other Operating Activity | 5,852 | 21,389 | 7 | 13,339 | 5 |
| Operating Cash Flow | $-4,579 | $-2,737 | $0 | $-2,089 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,300 | N/A | N/A | N/A | N/A |
| PPE Investments | -7 | -25 | N/A | -9 | N/A |
| Purchase Of Investment | N/A | -373 | N/A | -399 | N/A |
| Purchase Sale Intangibles | N/A | -1,168 | N/A | -1,158 | N/A |
| Other Investing Activity | 0 | -1,302 | 0 | -1,161 | 0 |
| Investing Cash Flow | $-1,307 | $-1,700 | $N/A | $-1,569 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 930 | N/A | 930 | N/A |
| Common Stock Issued | 9,276 | 3,476 | N/A | 2,765 | N/A |
| Other Financing Activity | -898 | 32 | 0 | -45 | 0 |
| Financing Cash Flow | $8,378 | $4,438 | $N/A | $3,650 | $N/A |
| Beginning Cash Position | 11 | 10 | 4 | 10 | 4 |
| End Cash Position | 2,504 | 11 | 4 | 2 | 4 |
| Net Cash Flow | $2,492 | $1 | $0 | $-8 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,579 | -2,737 | 0 | -2,089 | 0 |
| Capital Expenditure | -7 | -25 | N/A | -9 | N/A |
| Free Cash Flow | -4,585 | -2,762 | 0 | -2,097 | 0 |